IOL Chemicals & Pharmaceuticals Quarterly Results for Trading Insights

IOLCP • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹30 Cr
QSept 2025
Quarterly Results

IOL Chemicals & Pharmaceuticals Quarterly Results Key Highlights

  • Revenue of ₹574 Cr in Sept 2025 (+7.9% vs Mar 2025, +7.9% vs Sept 2024)
  • Net Profit of ₹30 Cr in Sept 2025 (-3.2% vs Mar 2025, +57.9% vs Sept 2024)
  • EBITDA of ₹64 Cr in Sept 2025 (-4.5% vs Mar 2025)
  • Operating Margin of 10.0% in Sept 2025 (-2.0pp vs Mar 2025)
  • Earnings Per Share of ₹1.02 in Sept 2025 (-4.7% vs Mar 2025)

IOL Chemicals & Pharmaceuticals Quarterly Results Analysis

Metric Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 QoQ YoY
Revenue (₹ Cr) 574 532 559 586 532 7.9% 7.9%
Net Profit (₹ Cr) 30 31 34 21 19 - -
EBITDA (₹ Cr) 64 67 70 51 48 - -
EPS (₹) 1.02 1.07 1.16 0.70 3.26 - -
Operating Margin (%) 10.0% 12.0% 11.0% 8.0% 8.0% - -

IOL Chemicals & Pharmaceuticals Share Price Trend Around Quarterly Results

Visualize IOL Chemicals & Pharmaceuticals's 1-year price movement across quarterly results — ideal for logging trades in Tickjournal. All values in ₹.

Related Pages for IOL Chemicals & Pharmaceuticals

Additional stock information and data for IOLCP

IOLCP stock live price
IOLCP PE ratio trends
IOLCP 52-week performance

Profitability Ratios

Profit Margin 5.2%
EBITDA Margin 11.1%
Operating Margin 10.0%
ROE (Annual) 7.1%

Balance Sheet Highlights

Total Assets ₹2,382 Cr
Total Equity ₹1,688 Cr
Current Assets ₹1,151 Cr
Current Liabilities ₹85 Cr

Cash Flow Analysis

Operating Cash Flow ₹179 Cr
Investing Cash Flow ₹-154 Cr
Financing Cash Flow ₹46 Cr
Net Cash Flow ₹71 Cr

Current Market Data

Current Price ₹80.54
Exchange NSE
Last Updated Apr 08, 2026

Revenue Trend (₹ Cr)

Dec 2025 586
Jun 2025 559
Mar 2025 532
Sept 2025 574

Net Profit Trend (₹ Cr)

Dec 2025 21
Jun 2025 34
Mar 2025 31
Sept 2025 30

Operating Margin Trend (%)

Dec 2025 8.0%
Jun 2025 11.0%
Mar 2025 12.0%
Sept 2025 10.0%

Sector Competitors - Quarterly Performance Comparison

Comparing IOL Chemicals & Pharmaceuticals quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹406,351.37 Cr 1714.6 14,875 3,125 +10.8% - 21.0% 131.9
Divis Laboratories
Sept 2025 		₹155,471.67 Cr 5882.0 2,860 689 +7.1% - 24.1% 226.5
Torrent Pharmaceuti…
Sept 2025 		₹134,945.00 Cr 4029.2 3,219 591 +11.3% - 18.4% 229.7
Lupin
Sept 2025 		₹102,578.78 Cr 2294.1 6,921 1,485 +23.2% - 21.5% 70.9
Dr Reddys Laborator…
Sept 2025 		₹101,601.09 Cr 1191.4 9,135 1,337 +1.1% - 14.6% 73.6
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores